Profusa, Inc. Common Stock

Day range

$0.74 – $0.82

Open

$0.77

Prev close

$0.84

Volume

362.72K

Market cap

$508.2K

Shares out

605.65K

P/E

—

P/S

—

P/B

-0.02

P/FCF

—

ROE

158.4%

ROA

-4123.8%

Debt/Equity

-0.33

Div yield

0.00%

As of Oct 23, 2026

• Debt issuanceOct 15, 2026

  On October 15, 2026, pursuant to the Purchase Agreement, the Company issued to Ascent a Senior Secured Convertible Promissory Note in the principal amount of $769,230.77, for a purchase price of $700,000.00. The Note was issued with original issue discount.

• Internal control weaknessOct 9, 2026

  The material weaknesses in the Company's internal control over financial reporting related to the lack of segregation of duties in the financial statement close process, lack of review controls and expertise to ensure accurate valuations and accounting of financial instruments, and lack of technical accounting expertise and internal controls to ensure accurate preparation of financial statements in accordance with U.S. GAAP including complex debt and equity instruments. The material weaknesses had not been remediated as of June 30, 2026.

• Debt issuanceOct 5, 2026

  The Company issued to Ascent “a Senior Secured Convertible Promissory Note in the principal amount of $555,555.55, for a purchase price of $500,000.00, maturing April 2, 2027,” and “a Senior Secured Convertible Promissory Note in the principal amount of $1,111,111.11, for a purchase price of $1,000,000.00, maturing April 20, 2027.”

• Special meeting resultsSep 21, 2026

  On September 18, 2026, the Company held a Special Meeting of Stockholders... The stockholders were asked to approve an amendment to the Company's Amended and Restated Certificate of Incorporation... to... effect one or more reverse stock splits... The vote was as follows: FOR 262,920; AGAINST 17,360; ABSTAIN 7,610; BROKER NON-VOTES 0.

• Debt issuanceSep 16, 2026

  On September 16, 2026, ... the Company issued to Ascent a Senior Secured Convertible Promissory Note in the aggregate principal amount of $384,615.38 ... for an aggregate purchase price of $350,000.00 (reflecting original issue discount). The Note ... matures on the earlier of (i) September 16, 2027 and (ii) the Option Closing Date.

Days to cover

1.0

Short interest

160.65K

Avg volume

9.02M

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Profusa Submits Response Package to GMED as Part of Ongoing CE Mark Review Process for Lumee® Oxygen Platform
  positiveGlobeNewswire Inc.· Jun 12, 2026
• Profusa Receives Favorable Nasdaq Listing Determination
  negativeGlobeNewswire Inc.· May 8, 2026
• What's Going On With Profusa Stock Tuesday?
  negativeBenzinga· Apr 7, 2026
• Profusa Stock Soars On Deal Targeting Multi Billion Precision Diagnostics Space
  positiveBenzinga· Apr 6, 2026
• Profusa Bolsters European Commercial Network with New French Distributor, MedSell
  positiveGlobeNewswire Inc.· Dec 31, 2025